AGI AGI

 

TIDMAGI 
 
RNS Number : 9414G 
AGI Therapeutics plc 
10 February 2010 
 
 
 
                          AGI Therapeutics plc ('AGI') 
 
                               Holding in Company 
 
 
 
AGI was notified on 9 February 2010 that Edinburgh Partners Limited, having 
assumed management of certain funds previously managed by F&C Management 
Limited, had decreased its shareholding to 2,969,576 Ordinary Shares 
representing 4.41% of AGI's Issued Share Capital. 
 
 
 
Contact Information 
 
AGI Therapeutics 
 
David G. Kelly, Chief Financial Officer   Tel: +353 1 449 3254 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 HOLURVKRRWAUARR 
 

AGI (LSE:AGI)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025

AGI (LSE:AGI)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025